News & Updates

Show Multimedia Only
Adding cyclophosphamide to glucocorticoids confers no survival benefit in IPF

Adding cyclophosphamide to glucocorticoids confers no survival benefit in IPF

24 Sep 2021
Tofacitinib may promote HBV reactivation in certain RA patients

Tofacitinib may promote HBV reactivation in certain RA patients

24 Sep 2021

Use of tofacitinib for rheumatoid arthritis (RA) may lead to reactivation of hepatitis B virus (HBV), especially among hepatitis B surface antigen-positive (HBsAg+) and HBsAg-negative/hepatitis B core antibody-positive (HBsAg–/HBcAb+) patients, according to a study from Taiwan.

Tofacitinib may promote HBV reactivation in certain RA patients

24 Sep 2021